Revvity, Inc. (RVTY)
(Real Time Quote from BATS)
$124.42 USD
-1.17 (-0.93%)
Updated Jul 30, 2024 01:14 PM ET
4-Sell of 5 4
D Value D Growth D Momentum D VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Net Sales: Life Sciences [$M] |
-- | 1,292 | 1,293 | 898 | 597 | 1,746 |
Net Sales: Diagnostics [$M] |
-- | 1,459 | 2,020 | 2,933 | 2,068 | 1,138 |
Income - Line of Business | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Adjusted operating income: Life S... |
-- | 489 | 503 | 282 | 267 | 338 |
Adjusted operating income: Diagno... |
-- | 321 | 782 | 1,433 | 1,010 | 316 |
Adjusted operating income: Corpor... |
-- | -40 | -73 | -77 | -74 | -58 |
NFM - Operating & Non Financial Metrics | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
Organic revenue growth - Life Sci... |
-- | 0 | 15 | 12 | -4 | 3 |
Organic revenue growth - Diagnost... |
-- | -27 | -29 | 35 | 81 | 7 |
Organic revenue growth - Total [%... |
-- | -16 | -29 | 24 | 31 | 5 |